Encube Ethicals has filed preliminary papers with capital markets regulator Securities and Exchange Board of India (SEBI) to raise Rs 3,000 crore through an Initial Public Offering (IPO). The company's maiden IPO is completely an offer for sale by the promoter Mehul Madhusudan Shah and existing shareholder Frontier Investment Holdings.
Since it's an OFS, the company will not receive any proceeds from the public issue, instead funds will go to selling shareholders. JM Financial, Axis Capital, and Kotak Mahindra Capital Company are the book running lead managers to the issue. The shares are proposed to be listed on the BSE and NSE.
Encube Ethicals is a global specialty pharmaceutical formulations platform with deep domain expertise in technically complex topical and transdermal dosage forms.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1949.00 |
| Dr. Reddys Labs. | 1172.00 |
| Cipla | 1472.00 |
| Lupin | 2360.00 |
| Zydus Lifesciences | 1115.20 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: